BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

InteKrin Therapeutics 

4300 El Camino Real
Suite 201
Los Altos  California  94022  U.S.A.
Phone: 650-941-5501 Fax: 866-286-2242


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone 6/29/2010 8:52:18 AM    More...
InteKrin Therapeutics to Present Phase 2b Clinical Data for Edema at the 2010 American Diabetes Association Annual Meeting 6/18/2010 10:20:58 AM    More...
InteKrin Therapeutics Appoints Linda Higgins, PhD as President and Chief Executive Officer 5/10/2010 6:48:12 AM    More...
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development 4/23/2010 9:54:42 AM    More...
InteKrin Therapeutics' Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School 2/8/2010 8:14:04 AM    More...
InteKrin Therapeutics to Present at the 28th Annual JP Morgan Healthcare Conference on Monday, January 11, 2010 1/11/2010 9:00:05 AM    More...
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting 9/30/2009 9:28:51 AM    More...
InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting 9/30/2009 9:10:20 AM    More...
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer 9/15/2009 8:38:45 AM    More...
InteKrin Therapeutics Announces Appointment of Geoffrey M. Parker as Chief Business Officer 7/13/2009 11:21:51 AM    More...
12